Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 10:02 PM
Study NCT ID:
NCT00445458
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2007-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-08
First Submit QC Date:
None
Study First Post Date:
2007-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-10
Results First Submit QC Date:
None
Results First Post Date:
2018-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-01-31
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-06-27
Last Update Post Date:
2018-07-26
Last Update Post Date Type:
ACTUAL